October 2025 FDA Recall Ketorolac Tromethamine by Aspiro Pharma Limited
D-0036-2026 - Presence of Particulate Matter

This Class II drug recall was voluntarily initiated by Aspiro Pharma Limited on October 1, 2025 for the product Ketorolac Tromethamine. The FDA reported the reason for recall as presence of particulate matter. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0036-2026

Reason for Recall
Presence of Particulate Matter: Particulate matter identified as glass
Initiated
10-01-2025
Reported
10-29-2025
Quantity

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Aspiro Pharma Limited
Nationwide within the United States
Ketorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL), 2 mL Single-Dose Vial, For Intramuscular Use Only, Rx only, Mfd. for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Mfd. by: ASPIRO PHARMA LIMITED, Telangana - 502281, INDIA., U.S. Contact Number: 1-866-495-1995, NDC 31722-307-25 (Carton), 31722-307-02 (Vial label).

Batch or Lot Expiration Information

Lot# : AS1240347A, Exp Date 09/2026; AS1240144A, Exp Date 05/2026; AS1240145A, AS1240146A, Exp Date 06/2026; AS1250295A, Exp Date 05/2027.